Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro

被引:7
作者
Shen, Yang [1 ]
Wu, Yanting [1 ]
Lu, Qing [1 ]
Zhang, Peili [1 ]
Ren, Mulan [1 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Obstet & Gynecol, Nanjing 210009, Jiangsu, Peoples R China
关键词
Uterine leiomyoma (UL); Environmental estrogens (EEs); Bisphenol A; Octylphenol (OP); Nonylphenol (NP); Estrogen receptor (ER); Transforming growth factor-beta (TGF-beta); TGF-BETA; INCREASED EXPRESSION; BREAST-CANCER; CELLS; PROLIFERATION; FACTOR-BETA-3; THERAPY;
D O I
10.1007/s13277-015-3813-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this paper is to study the participation of transforming growth factor-beta (TGF-beta) signaling pathway in mediating the growth of human uterine leiomyoma (UL) activated by phenolic environmental estrogens (EEs), via the interaction between TGF-beta and ER signaling pathways. The UL cells were prepared by primary culture and subculture methods. To validate the role of TGF-beta 3 (5 ng/ml) for the viability of human uterine leiomyoma cells, CCK-8 assay was performed in each of five treatment groups including E-2 group (E-2 10(9) mol/l), BPA group (bisphenol A 10 mu mol/l), NP group (nonylphenol 32 mu mol/l), OP group (octylphenol 8 mu mol/l), or control group (DMSO only). Subsequently, qRT-PCR was applied to detect mRNA expressions of ER alpha and c-fos, while western blot assay was used to test the expressions of p-Smad3, SnoN, and c-fos proteins in all settings mentioned above; the expressions were compared among different groups, and also in settings with and without synchronous treatment of ICI 182,780. Primarily cultured UL cells were successfully established. Compared with the control group, there were statistically significant increases in the proliferation rate of the UL cells in all EE groups or treated with TGF-beta 3 only (p < 0.05). Nevertheless, a slight decrease in proliferation rate of UL was detected in coexistence with TGF-beta 3 in all EE groups (p > 0.05). Interestingly, mRNA expressions of ER alpha and c-fos reduced in the setting of coexistence of TGF-beta 3 and EEs compared to isolated EE treatment (p < 0.05). Compared with the control group, the expression of p-Smad3 and c-fos proteins significantly decreased (p < 0.05) in each of E-2, BPA, NP, and OP group, and the expression of SnoN protein also significantly reduced only in BPA and NP groups (p < 0.05), followed by TGF-beta 3 treatment. When adding ICI 182,780, the expression of p-Smad3 protein significantly increased in OP group (p < 0.05), but slightly increased in E-2, BPA, NP, and OP groups (p > 0.05). However, compared with the control group, the expressions of SnoN and c-fos proteins significantly decreased (p < 0.05) after adding ICI182,780. Moreover, there was a significant statistical difference in the expression of p-Smad3, SnoN, and c-fos proteins between pre- and post-treatment of ICI 182,780 in all groups (p < 0.05). The ER alpha signaling pathway and TGF-beta signaling pathway have different roles in the control of UL cell proliferation. The phenolic EEs can be a promoter of UL cell proliferation, which is mediated by ER alpha signaling pathway and its cross-talking with TGF-beta signaling pathway. Both less exposure to EEs and blockade of TGF signaling pathway are necessary strategies to prevent UL.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 29 条
[1]   Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation [J].
Arici, A ;
Sozen, I .
FERTILITY AND STERILITY, 2000, 73 (05) :1006-1011
[2]   Crosstalk of TGF-β and Estrogen Receptor Signaling in Breast Cancer [J].
Band, Arja M. ;
Laiho, Marikki .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2011, 16 (02) :109-115
[3]  
Borahay MA, 2015, MOL MED
[4]   The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy [J].
Chegini, N ;
Luo, XP ;
Ding, L ;
Ripley, D .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 209 (1-2) :9-16
[5]   Proinflammatory and Profibrotic Mediators: Principal Effectors of Leiomyoma Development as a Fibrotic Disorder [J].
Chegini, Nasser .
SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (03) :179-202
[6]   A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells [J].
Di, Xudong ;
Andrews, Danica M. K. ;
Tucker, Charles J. ;
Yu, Linda ;
Moore, Alicia B. ;
Zheng, Xiaolin ;
Castro, Lysandra ;
Hermon, Tonia ;
Xiao, Hang ;
Dixon, Darlene .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (04) :281-292
[7]   Proliferation of estrogen receptor-α-positive mammary epithelial cells is restrained by transforming growth factor-β1 in adult mice [J].
Ewan, KBR ;
Oketch-Rabah, HA ;
Ravani, SA ;
Shyamala, G ;
Moses, HL ;
Barcellos-Hoff, MH .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (02) :409-417
[8]   Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics [J].
Figueroa, Jonine D. ;
Flanders, Kathleen C. ;
Garcia-Closas, Montserrat ;
Anderson, William F. ;
Yang, Xiaohong R. ;
Matsuno, Rayna K. ;
Duggan, Maire A. ;
Pfeiffer, Ruth M. ;
Ooshima, Akira ;
Cornelison, Robert ;
Gierach, Gretchen L. ;
Brinton, Louise A. ;
Lissowska, Jolanta ;
Peplonska, Beata ;
Wakefield, Lalage M. ;
Sherman, Mark E. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (03) :727-735
[9]   Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway [J].
Goto, Natsuka ;
Hiyoshi, Hiromi ;
Ito, Ichiaki ;
Tsuchiya, Mai ;
Nakajima, Yuka ;
Yanagisawa, Junn .
CANCER SCIENCE, 2011, 102 (08) :1501-1508
[10]   1,25-Dihydroxyvitamin D3 Reduces TGF-β3-Induced Fibrosis-Related Gene Expression in Human Uterine Leiomyoma Cells [J].
Halder, Sunil K. ;
Goodwin, J. Shawn ;
Al-Hendy, Ayman .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :E754-E762